280 likes | 441 Views
Pulmonary complications in a child with AML. CHILDREN’S HOSPITAL & RESEARCH CENTER OAKLAND Hazel Villa, MD . Background. LC,11 y/o girl AMLM1 at 20 months old 1 st transplant (BMT) at 2 y/o–HLA-matched sibling donor Recurrent cutaneous disease at 3 y/o
E N D
Pulmonary complications in a child with AML CHILDREN’S HOSPITAL & RESEARCH CENTER OAKLAND Hazel Villa, MD
Background • LC,11 y/o girl • AMLM1 at 20 months old • 1st transplant (BMT) at 2 y/o–HLA-matched • sibling donor • Recurrent cutaneous disease at 3 y/o • 2nd transplant peripheral stem cell at 3 y/o • -same sibling donor
Background • First transplant: BMT • 1.Induction chemotherapy: Idarubicin, Ara-C, Etoposide, 6-thioguanine, dexamethasone • 2. Preparation for transplant: myeloablation with : • Busulfan, CyclophosphamideCytoxan • 3. Prophylaxis for GVHD: Methotrexate
Background • 2nd transplant : peripheral stem cell transplant • ( She had cutaneous relapse) • 1.Preparation for SCT: total body irradiation • chemotherapy with: Etoposide, cyclophosphamide • 2.GVHD prevention with Methotrexate
Background • 10/2003-1/2004 (5 months post SCT) • Chronic GVHD!!! • Oral lesionsbudesonide topical • Crackles- chest CT: mosaic perfusion • Flovent 44 2 puffs BID • Cyclosporine
2-4 years after 2nd transplant ( Patient is 4-6 years of age) • Asymptomatic • PFT • FVC 94 • pre FEV1 68 • post FEV1 74 • FEV1/FVC 62 • TLC 142 • RV 259 • DLCO- normal • Flovent BID /Albuterol MDI prn
Disease Progression • 7 years post 2nd transplant ( patient was 10 y/o) • Admitted from the ED for respiratory distress • Treated for community acquired pneumonia
Patient was re-admitted * CXR –increased infiltrates on the right * Chest CT :
* Flexible bronchoscopy: normal anatomy • * BAL: AFB result was pending, NURF • Treatment intensified • * Plan to start azithromycin for BO, if TB negative
BAL : Mycobacterium kansasii • Quantiferon Gold –negative • INH, RIF, EMB • * Airway clearance therapy was continued
BOS or BOOP/COP INFECTION BOS/BOOP PROGRESSION REMOVE THE CYST OR NOT ?
Pulmonary Plan: * Agree with immunosuppression if (-) pneumothorax, (-) chest tube * Resection of the enlarging cyst. (Blebectomy preferred, pt has low lung reserve) * NO pleurodesis for recurrent pneumothorax, if lung transplant is an option * Favor Azithromycin (BOS/ NTB) Prednisone (BOS/Immunosuppresion)
Course: * Underwent blebectomy- lung tissue sent for histopathology * No recurrence of pneumothorax post-blebectomy * Started on cyclosporine and prednisone * Now 4-drug treatment for M. kansasii (+ Azithromycin) Outpatient follow up: 10/4/10 * Pt doing well. * Started on cyclosporine and prednisone per Heme- Oncology
Histopathological Report • No evidence of recurrent AML • Areas of obliterated bronchioles show mature collagenous fibrosis • No interstitial scarring in most of the damaged airways. • No features of cryptogenic organizing pneumonia (COP).
ORGANIZING FIBRINOUS PLEURITIS CONSISTENT WITH PNEUMOTHORAX OBLITERATIVE BRONCHIOLITIS CONSISTENT WITH PULMONARY GRAFT VERSUS HOST DISEASE
Thank you very much!!!